Trials / Unknown
UnknownNCT04937309
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea
Efficacy and Safety of Non Invasive Vagal Stimulation to Prevent Chemotherapy-induced Nausea in Patients With Breast Cancer Receiving Anthracycline and Cyclophosphamide Chemotherapy
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 338 (estimated)
- Sponsor
- University Hospital, Tours · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Despite pharmaceutical innovations, chemotherapy induced nausea is frequent and largely participating to alter our patients quality of life. Non invasive vagal stimulation is approved in other health issues, for example in headache or gastroparesis, with a reported benefit on nausea. This study aims to analyse if a non invasive vagal stimulation could better prevent chemotherapy induced nausea, in addition to standard treatment, in breast cancer patients treated with cyclophosphamide and anthracycline.
Detailed description
Despite pharmaceutical innovations, chemotherapy induced nausea is frequent and largely participating to alter our patients quality of life. Non invasive vagal stimulation is approved in other health issues, for example in headache or gastroparesis, with a reported benefit on nausea. This study aims to analyse if a non invasive vagal stimulation could better prevent chemotherapy induced nausea, in addition to standard treatment, in breast cancer patients treated with cyclophosphamide and anthracycline.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | non invasive auricular vagal stimulation | Stimulation twice a day, beginning the day before until the fourth day after chemotherapy, for the three first chemotherapy cycles |
| DRUG | usual medical treatment | Standard anti emetic treatments to prevent emesis due to chemotherapy |
| DEVICE | sham stimulation | Stimulation twice a day, beginning the day before until the fourth day after chemotherapy, for the three first chemotherapy cycles, with a sham device |
Timeline
- Start date
- 2022-06-24
- Primary completion
- 2024-02-15
- Completion
- 2024-05-01
- First posted
- 2021-06-24
- Last updated
- 2023-05-11
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT04937309. Inclusion in this directory is not an endorsement.